IL6 and triple-negative breast carcinoma: We report here that treatment of triple-negative breast cancer cells with RA in vitro activated the pro-invasive Src-YAP-IL6 axis in MDA-MB-231 cells and inactivated this signaling pathway in MDA-MB-468 cells.